Rational Pharmacotherapy in Cardiology

Advanced search


Full Text:


The present review is focuses on new onset atrial fibrillation (AF) in conditions of acute coronary syndrome (ACS). Literature sources from PubMed and Scopus was used. AF is common in the general population and in the ACS population, at that new onset AF, and AF, which was by the time of ACS development are determined. Appearance of AF is more likely amongst the elderly patients with congestive heart failure, with signs of the hemodynamic instability and with the left atrium dilatation. It is well-known about the predictors of adverse outcome in ACS. According to some literature data new onset AF leads to worsening of prognosis, and in line with other sources a reason of its association with high level of mortality is due to the severity of ACS and appearance of AF is not independent predictor of death. The absence of subjective symptoms at the time of paroxysm of new onset AF does not allow estimating its duration and distinguishing between the new onset AF, persistent and constant AF. It is possible to trace the relationship between the myocardial ischemia and AF appearance. Inefficient reperfusion during percutaneous coronary intervention or thrombolytic therapy is accompanied by the onset of AF, on the contrary, when effective patency of coronary artery is achieved, AF appears significantly less often. New onset AF in ACS, in particular, accompanied by cardiogenic shock, requires emergency pharmacological or electrical cardioversion. In some cases, active cardioversion is not necessary, because of spontaneous cardiac rhythm conversion. In conclusions, it is necessary to point out, that ambiguity and multifactority of this problem demands investigation of arrhythmogenesis mechanisms and development of special risk stratification instruments for the new onset AF in ACS.

About the Authors

G. S. Galjautdinov1
Kazan Medical University
Russian Federation

MD, PhD, Professor, Chair of Hospital Therapy,

Butlerova ul. 49, Kazan, 420012

I. V. Gorelkin
Kazan City Clinical Hospital N7
Russian Federation

MD, Internist,

Marshala Chuykova ul. 54, Kazan, 420103

K. R. Ibragimova
Kazan City Clinical Hospital N7
Russian Federation

MD, Clinical Pharmacologist,

Marshala Chuykova ul. 54, Kazan, 420103

R. R. Sadriev
Kazan City Clinical Hospital N7
Russian Federation

MD, Chief Specialist in Anesthesiology and Resuscitation,

Marshala Chuykova ul. 54, Kazan, 420103


1. Schmitt J., Duray G., Gersh B.J., Hohnloser S.H. Atrialfibrillationinacutemyocardialinfarction: asystematic review of the incidence, clinical features and prognostic implications. Eur Heart J. 2009;30(9):1038-45. doi: 10.1093/eurheartj/ehn579.

2. Pérez-Villacastín J., Pérez Castellano N., Moreno Planas J. Epidemiology of Atrial Fibrillation in Spain in the Past 20 Years. Revista Española de Cardiología (English Edition). 2013;66(7):561-5. doi: 10.1016/j.rec.2013.02.012.

3. Petersen P. Thromboembolic complications in atrial fibrillation. Stroke. 1990;21(1):4-13. doi: 10.1161/01.STR.21.1.4.

4. Chugh S.S., Havmoeller R., Narayanan K., et al. Worldwide epidemiology of atrial fibrillation: a Global Burden of Disease 2010 Study. Circulation. 2014;129:837-47. doi: 10.1161/CIRCULATIONAHA.113.005119.

5. Braga C.G., Ramos V., Martins J., et al. Impact of atrial fibrillation type during acute coronary syndromes: Clinical features and prognosis. Portuguese Journal of Cardiology. 2015;34(6):403-10. doi: 10.1016/j.repc.2015.01.010.

6. Alshengeiti L., Elbarouni B., Yan R.T., et al. Management and outcome of acute coronary syndrome patients in relation to prior history of atrial fibrillation. Canadian Journal of Cardiology. 2012;28(4):443-9. doi: 10.1016/j.cjca.2011.12.011.

7. Jabre P., Jouven X., Adnet F., et al. Atrial fibrillation and death after myocardial infarction. Circulation. 2011;123(19):2094-100. doi: 10.1161/CIRCULATIONAHA.110.990192.

8. Lehto M., Snapinn S., Dickstein K., et al. Prognostic risk of atrial fibrillation in acute myocardial infarction complicated by left ventricular dysfunction: the OPTIMAAL experience. Eur Heart J. 2004;26(4):350-6. doi: 10.1093/eurheartj/ehi064.

9. González-Pacheco H., Márquez M.F., Arias-Mendoza A., et al. Clinical features and in -hospital mortality associated with different types of atrial fibrillation in patients with acute coronary syndrome with and without ST elevation. Journal of Cardiology. 2015;66(2):148-54. doi: 10.1016/j.jjcc.2014.11.001.

10. Lopes R.D., Pieper K.S., Horton J.R., et al. Short-and long-term outcomes following atrial fibrillation in patients with acute coronary syndromes with or without ST-segment elevation. Heart (British Cardiac Society). 2008;94(7):867-73. doi: 10.1136/hrt.2007.134486.

11. Ribeiro V., Pereira M., Melão F., et al. Determinants and outcomes of atrial fibrillation complicating myocardial infarction: the EURHOBOP study in Portugal. International Journal of Cardiology. 2014;176(3):1426-8. doi: 10.1016/j.ijcard.2014.08.042.

12. Galvao Braga C., Ramos V., Vieira C., et al. New-onset atrial fibrillation during acute coronary syndromes: predictors and prognosis. Revista Portuguesa de Cardiologia (English Edition) 2014;33(5):281-7. doi: 10.1016/j.repc.2013.10.017.

13. Consuegra-Sáncheza L., Melgarejo-Morenob A., Galcerá-Tomásc J., et al. Short-and long-term prognosis of previous and new-onset atrial fibrillation in ST-segment elevation acute myocardial infarction. Revista Española de Cardiología (English Edition). 2015;68(1):31-8. doi: 10.1016/ j.rec.2014.03.017.

14. Jabre P., Roger V.L., Murad M.H., et al. Mortality associated with atrial fibrillation in patients with myocardial infarction. Circulation. 2011;123(15):1587-93. doi: 10.1161/CIRCULATIONAHA.110.986661.

15. Lau D.H., Alasady M., Brooks A.G., et al. New-onset atrial fibrillation and acute coronary syndrome. Expert Review of Cardiovascular Therapy. 2010;8(7):941-8. doi: 10.1586/erc.10.61.

16. Rathore S. S., Berger A. K., Weinfurt K. P., et al. Acute myocardial infarction complicated by atrial fibrillation in the elderly. Circulation. 2000;101(9):969-74. doi: 10.1161/01.CIR.101.9.969

17. Mehta R.H., Califf R.M., Yang Q., et al. Impact of initial heart rate and systolic blood pressure on relation of age and mortality among fibrinolytic-treated patients with acute ST-elevation myocardial infarction presenting with cardiogenic shock. The American Journal of Cardiology. 2007;99(6):793- 6. doi: 10.1016/j.amjcard.2006.10.035.

18. Terkelsen C.J., Sorensen J.T., Kaltoft A.K., et al. Prevalence and significance of accelerated idioventricular rhythm in patients with ST-elevation myocardial infarction treated with primary percutaneous coronary intervention. The American Journal of Cardiology. 2009;104(12)1641-6. doi: 10.1016/j.amjcard.2009.07.037.

19. Tatli E., Alicik G., Buturak A., et al. Arrhythmias following revascularization procedures in the course of acute myocardial infarction: are they indicators of reperfusion or ongoing ischemia? The Scientific World Journal. 2013;2013:160380. doi: 10.1155/2013/160380.

20. Rene A.G., Généreux P., Ezekowitz M., et al. Impact of atrial fibrillation in patients with ST-elevation myocardial infarction treated with percutaneous coronary intervention (from the HORIZONS-AMI [Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction] trial). The American Journal of Cardiology. 2014;113(2):236-42. doi: 10.1016/j.amjcard.2013.09.016.

21. Wynn G.J., Todd D.M., Webber M., et al. The European Heart Rhythm Association symptom classification for atrial fibrillation: validation and improvement through a simple modification. Europace. 2014;16(7):965-72. doi: 10.1093/europace/eut395.

22. Kirchhof P., Benussi S., Kotecha D., et al. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS The Task Force for the management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC Endorsed by the European Stroke Organization (ESO). European Journal of Cardiothoracic Surgery. 2016;50(5):e1-e88. doi:10.1093/eurheartj/ehw210.

23. Siontis K.C., Gersh B.J., Killian J.M., et al. Typical, atypical, and asymptomatic presentations of newonset atrial fibrillation in the community: characteristics and prognostic implications. Heart Rhythm. 2016;13(7):1418-24. doi: 10.1016/j.hrthm.2016.03.003.

24. Stamboul K., Zeller M., Fauchier L., et al. Prognosis of silent atrial fibrillation after acute myocardial infarction at 1-year follow up. Heart. 2015;101(11):864-9. doi: 10.1136/heartjnl2014-307253.

25. Stamboul K., Zeller M., Fauchier L., Gudjoncik A. Incidence and prognostic significance of silent atrial fibrillation in acute myocardial infarction. International Journal of Cardiology. 2014;174(3):611-7. doi: 10.1016/j.ijcard.2014.04.158.

26. Jons C., Jacobsen U.G., Joergensen R.M., et al. Cardiac Arrhythmias and Risk Stratification after Acute Myocardial Infarction (CARISMA) Study Group. The incidence and prognostic significance of new-onset atrial fibrillation in patients with acute myocardial infarction and left ventricular systolic dysfunction: a CARISMA substudy. Heart Rhythm. 2011;8(3):342-8. doi: 10.1016/ j.hrthm.2010.09.090.

27. Senoo K., Lip G.Y. Prediction of stroke in patients without atrial fibrillation using the CHADS2 and CHA2DS2-VASc scores: a justification for more widespread thromboprophylaxis? Heart. 2014; 100(19):1485-6. doi: 10.1136/heartjnl-2014-306161.

28. Chen M.C., Chang J.P., Liu W.H., et al. Increased inflammatory cell infiltration in the atrial myocardium of patients with atrial fibrillation. The American Journal of Cardiology. 2008;102(7):861-5. doi: 10.1016/j.amjcard.2008.05.038.

29. Platonov P.G., Mitrofanova L.B., Orshanskaya V., et al. Structural abnormalities in atrial walls are associated with presence and persistency of atrial fibrillation but not with age. Journal of the American College of Cardiology. 2011;58(21):2225-32. doi: 10.1016/j.jacc.2011.05.061.

30. Kainuma S., Masai T., Yoshitatsu M., et al. Advanced left-atrial fibrosis is associated with unsuccessful maze operation for valvular atrial fibrillation. European Journal of Cardio-Thoracic Surgery. 2011;40(1):61-9. doi: 10.1016/j.ejcts.2010.11.008.

31. Lip, G. Y., Nieuwlaat, R., Pisters, R., et al. Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation. Chest Journal. 2010;137(2):263-72. doi: 10.1378/chest.09-1584

32. Hrynkiewicz-Szymanska A., Dluzniewski M., Platek A.E., Szymanski F.M., et al. Association of the CHADS2 and CHA2DS2-VASc scores with left atrial enlargement: a prospective cohort study of unselected atrial fibrillation patients. Journal of Thrombosis and Thrombolysis. 2015;40(2): 240-7. doi: 10.1007/s11239-014-1154-6.

33. Saliba W., Gronich N., Barnett-Griness O., et al. Usefulness of CHADS2 and CHA2DS2-VASc scores in the prediction of new-onset atrial fibrillation: a population-based study. The American Journal of Medicine. 2016;129(8):843-9. doi: 10.1016/j.amjmed.2016.02.029.

34. Wessler B.S., Kent D.M. Controversies in cardioembolic stroke. Current Treatment Options in Cardiovascular Medicine. 2015;17(1):358. doi: 10.1007/s11936-014-0358-6.

35. Suissa L., Bertora D., Lachaud S., et al. Score for the targeting of atrial fibrillation (STAF): a new approach to the detection of atrial fibrillation in the secondary prevention of ischemic stroke. Stroke. 2009;40(8):2866-8. doi: 10.1161/STROKEAHA.109.552679.

36. Malik S., Hicks W.J., Schultz L., et al. Development of a scoring system for atrial fibrillation in acute stroke and transient ischemic attack patients: the LADS scoring system. Journal of the Neurological Sciences. 2011;301(1-2):27-30. doi: 10.1016/j.jns.2010.11.011.

37. Fujii S., Shibazaki K., Kimura K., Sakai K., et al. A simple score for predicting paroxysmal atrial fibrillation in acute ischemic stroke. Journal of the Neurological Sciences. 2013;328(1-2):83-6. doi: 10.1016/j.jstrokecerebrovasdis.2015.06.019.

38. Gal P., Parlak E., Demirel F., et al. Prognostic significance of incident atrial fibrillation following STEMI depends on the timing of atrial fibrillation. Netherlands Heart Journal. 2015;23(9):430-5. doi: 10.1007/s12471-015-0709-2.

39. Saczynski J.S., McManus D., Zhou Z., et al. Trends in atrial fibrillation complicating acute myocardial infarction. The American Journal of Cardiology. 2009;104(2):169-74. doi: 10.1016/j.amjcard.2009.03.011.

40. Beukema R.J., Elvan A., Ottervanger J.P., et al. Atrial fibrillation after but not before primary angioplasty for ST-segment elevation myocardial infarction of prognostic importance. Netherlands Heart Journal. 2012;20(4):15-60. doi: 10.1007/s12471-012-0242-5.

41. Gorenek B., Birdane A., Unalir A., et al. Restoring sinus rhythm in patients with atrial fibrillation complicating acute myocardial infarction: Comparison the outcomes of primary angioplasty and thrombolytic therapy. European Journal of Heart Failure. 2000;2(1):32. doi: 10.1016/S1388-9842(00)80116-6.

42. Potpara T.S., Stankovic G.R., Beleslin B.D., et al. A 12-year follow-up study of patients with newly diagnosed lone atrial fibrillation: implications of arrhythmia progression on prognosis: the Belgrade Atrial Fibrillation study. Chest. 2012;141(2):339-347. doi: 10.1378/chest.11-0340.

43. Gómez-Outes A., Lagunar-Ruíz J., Terleira-FernándezAI., et al. Causes of death in anticoagulated patients with atrial fibrillation. Journal of the American College of Cardiology. 2016;68(23):2508- 21. doi: 10.1016/j.jacc.2016.09.944.

44. Smit M.D., Moes M.L., Maass A.H., et al. The importance of whether atrial fibrillation or heart failure develops first. European journal of heart failure 2012; 14(9): 1030-1040. doi: 10.1093/eurjhf/hfs097.

45. Worme M.D., Armstrong D.W., Tan M.K., et al. New onset atrial fibrillation in acute coronary syndrome: findings from the GRACE ECG substudy. Canadian Journal of Cardiology. 2016;32(3):s164. doi: 10.1016/j.cjca.2016.07.255.

46. Sinno H., Derakhchan K., Libersan D., et al. Atrial ischemia promotes atrial fibrillation in dogs. Circulation. 2003;107(14):1930-6. doi: 10.1161/01.CIR.0000058743.15215.03.

47. Alasady M., Abhayaratna W.P., Leong D.P., et al. Coronary artery disease affecting the atrial branches is an independent determinant of atrial fibrillation after myocardial infarction. Heart Rhythm. 2011;8(7):955-60. doi: 10.1016/j.hrthm.2011.02.016.

48. Thomas R.A., Rubio R., Berne R.M. Comparison of the adenine nucleotide metabolism of dog atrial and ventricular myocardium. Journal of Molecular and Cellular Cardiology. 1975;7(2):115-23. doi: 10.1016/0022-2828(75)90013-9

49. Kabell G., Buchanan L.V., Gibson J.K., et al. Effects of adenosine on atrial refractoriness and arrhythmias. Cardiovascular Research. 1994;28(9):1385-89.

50. Bertolet B.D., Hill J.A., Kerensky R.A., et al. Myocardial infarction related atrial fibrillation: role of endogenous adenosine. Heart (British Cardiac Society). 1997;78(1):88-90. doi: 10.1136/hrt. 78.1.88

51. Niccoli G., Scalone G., Lerman A., et al. Coronary microvascular obstruction in acute myocardial infarction. Eur Heart J. 2016;37(13):1024-33. doi: 10.1093/eurheartj/ehv484.

52. Jumeau C., Rupin A., Chieng-Yane P., et al. Direct Thrombin Inhibitors Prevent Left Atrial Remodeling Associated With Heart Failure in Rats. JACC: Basic to Translational Science. 2016;1(5):328-39. doi: 10.1016/j.jacbts.2016.05.002.

53. Heper G., Korkmaz M.E., Kilic A. Reperfusion arrhythmias: are they only a marker of epicardial reperfusion or continuing myocardial ischemia after acute myocardial infarction? Angiology. 2007;58(6):663-70. doi: 10.1177/0003319707308891.

54. Hassan W., Inam-ur-Rahim S., Hassan M., et al. Coronary artery percutaneous revascularization can be my best way for cardioversion: A case report. Interv Cardiol. 2017;9(3):117-22. doi: 10.4172/Interventional-Cardiology.1000565.

55. Krivonosov D.S., Tarasov N.I., Yurkin E.P., et al. Techniques of pre-admission cardioversion in patients with acute coronary syndrome complicated by a paroxysm atrial fibrillation for prevention of advance of ischemic myocardial damage. Vestnik Aritmologii. 2008;50:25-8. (In Russ.) [Кривоносов Д.С., Тарасов Н.И., Юркин Е.П. и др. Методы догоспитальной кардиоверсии у больных острым коронарным синдромом, осложненным пароксизмом фибрилляции предсердий, в профилактике прогрессирования ишемического повреждения миокарда. Вестник Аритмологии. 2008;50:25-8].

56. Ibanez B., James S., Agewall S., et al. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J. 2018;39(2):119-177. doi: 10.1093/eurheartj/ehx393

57. Pesaro A. E., SoeiroA.D. M., Serrano C.V., et al. Effect of β-blockers on the risk of atrial fibrillation with acute myocardial infarction. Clinics. 2010;65(3):265-270. doi: 10.1590/S1807- 59322010000300005.

58. Wi J., Shin D.H., Kim J.S., et al. Transient new-onset atrial fibrillation is associated with poor clinical outcomes in patients with acute myocardial infarction. Circulation Journal. 2016;80(7):1615-23. doi: 10.1253/circj.CJ-15-1250.

59. Kartal E., Ehlbi H., Alp A., et al. Predictors of new - onset atrial fibrillation after ST - segment elevation myocardial infarction in the elderly. Nobel Medicus Journal. 2015;11(3):22-7. doi: 10.1016/j.amjcard.2013.07.006.


For citations:

Galjautdinov1 G.S., Gorelkin I.V., Ibragimova K.R., Sadriev R.R. NEW-ONSET ATRIAL FIBRILLATION IN SETTINGS OF ACUTE CORONARY SYNDROME. CURRENT ISSUES. Rational Pharmacotherapy in Cardiology. 2018;14(3):451-457. (In Russ.)

Views: 1681

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.

ISSN 1819-6446 (Print)
ISSN 2225-3653 (Online)